New Delhi, March 24 (IANS) While new treatments in the form of drugs and injections have been developed to tackle global obesity, experts warn that maintaining a proper diet and exercise are essential for optimal results. According to global estimates, almost 2.3 billion people are living with overweight and obesity, with the numbers expected to rise by 2025.
The current drugs targeting obesity, such as semaglutide and other GLP-1 agonists, are primarily used for diabetes treatment. However, Dr. G. Moinoddin, a Consultant – Bariatric Laparoscopic Surgeon at Manipal Hospital, Bengaluru, emphasizes that these drugs alone are not sufficient for weight loss.
Weight loss typically becomes visible after 6-7 months of consistent use, with gradual progress over time. However, the high cost and potential gastrointestinal side effects, kidney problems, and pancreatitis may limit prolonged drug use. Stopping the drugs without proper lifestyle changes can lead to weight rebound.
A recent study published in the journal ‘eClinical Medicine’ highlighted the importance of exercise in maintaining a healthy weight after discontinuing obesity treatment. Dr. Ambrish Mithal, Chairman of Endocrinology and Diabetes at Max HealthCare, emphasized that supervised exercise plays a key role in weight maintenance post-treatment.
